Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review (Q37234350)

19 August 2017

0 references

1 reference

title

Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review (English)

1 reference

19 August 2017

heart rate variability

0 references

systematic review

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

Robert P Nolan

1

1 reference

19 August 2017

Philip Jong

2

1 reference

19 August 2017

Susan M Barry-Bianchi

3

1 reference

19 August 2017

Tim H Tanaka

4

1 reference

19 August 2017

John S Floras

5

1 reference

19 August 2017

1 August 2008

1 reference

European Journal of Cardiovascular Prevention and Rehabilitation

19 August 2017

1 reference

19 August 2017

15

1 reference

19 August 2017

4

1 reference

19 August 2017

386-396

1 reference

ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Dev

19 August 2017

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Heart rate variability: measurement and clinical utility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Parametric description of cardiac vagal control

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Sertraline treatment of major depression in patients with acute MI or unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Effect of verapamil on heart rate variability after an acute myocardial infarction. Danish Verapamil Infarction Trial II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Biofeedback treatment increases heart rate variability in patients with known coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Neural mechanisms of cardiovascular regulation during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Abnormalities of cardiac autonomic nervous activity correlate with expansive coronary artery remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

Effect of Beta-blockade on heart rate variability in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283030A97

10.1097/HJR.0B013E3283030A97

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference